Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. BTSG
stocks logo

BTSG

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
Intellectia AI SwingMax
Intellectia AI SwingMax

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q4
FY2026Q1
FY2026Q2
3.38B
+10.82%
0.350
+59.06%
3.27B
+13.48%
0.252
+32.46%
3.58B
+13.85%
0.291
+32.16%
Estimates Revision
The market is revising Upward the revenue expectations for BrightSpring Health Services, Inc. (BTSG) for FY2025, with the revenue forecasts being adjusted by 1.81% over the past three months. During the same period, the stock price has changed by 45.71%.
Revenue Estimates for FY2025
Revise Upward
up Image
+1.81%
In Past 3 Month
EPS Estimates for FY2025
Revise Upward
up Image
+6.34%
In Past 3 Month
Stock Price
Go Up
up Image
+45.71%
In Past 3 Month
Wall Street analysts forecast BTSG stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for BTSG is 38.89 USD with a low forecast of 30.00 USD and a high forecast of 42.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
11 Analyst Rating
Wall Street analysts forecast BTSG stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for BTSG is 38.89 USD with a low forecast of 30.00 USD and a high forecast of 42.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
10 Buy
1 Hold
0 Sell
Strong Buy
Current: 35.160
sliders
Low
30.00
Averages
38.89
High
42.00
Current: 35.160
sliders
Low
30.00
Averages
38.89
High
42.00
BMO Capital
Outperform
initiated
$40
2025-11-12
Reason
BMO Capital
Price Target
$40
2025-11-12
initiated
Outperform
Reason
BMO Capital initiated coverage of BrightSpring Health with an Outperform rating and $40 price target. BMO Capital sees a long runway for BrightSpring to sign additional limited distribution drug contracts while also benefiting from more generic conversions, which coupled with opportunities on the Provider Services side, support the firm's three-year 12%+ EBITDA growth outlook, the analyst tells investors in a research note.
Wells Fargo
Stephen Baxter
Overweight
maintain
$33 -> $39
2025-11-12
Reason
Wells Fargo
Stephen Baxter
Price Target
$33 -> $39
2025-11-12
maintain
Overweight
Reason
Wells Fargo analyst Stephen Baxter raised the firm's price target on BrightSpring Health to $39 from $33 and keeps an Overweight rating on the shares following Q3 earnings. The firm is also raising its estimates for pharmacy strength. Wells increased its EBITDA growth rate for 2026 to 15% from 11% previously due to annualizing strong second half of 2025 and a generally durable view of fundamentals.
Morgan Stanley
Erin Wright
upgrade
$32 -> $40
2025-11-07
Reason
Morgan Stanley
Erin Wright
Price Target
$32 -> $40
2025-11-07
upgrade
Reason
Morgan Stanley analyst Erin Wright raised the firm's price target on BrightSpring Health to $40 from $32 and keeps an Overweight rating on the shares.
Mizuho
Ann Hynes
maintain
$32 -> $38
2025-10-29
Reason
Mizuho
Ann Hynes
Price Target
$32 -> $38
2025-10-29
maintain
Reason
Mizuho analyst Ann Hynes raised the firm's price target on BrightSpring Health to $38 from $32 and keeps an Outperform rating on the shares.
UBS
Buy
maintain
$35 -> $42
2025-10-29
Reason
UBS
Price Target
$35 -> $42
2025-10-29
maintain
Buy
Reason
UBS raised the firm's price target on BrightSpring Health to $42 from $35 and keeps a Buy rating on the shares. BrightSpring's Q3 results were positive with another beat and raise quarter, with management expressing optimism around this momentum continuing into 2026, with a particular emphasis on the growth prospects within its infusion business, the analyst tells investors in a research note.
BTIG
David Larsen
Buy
maintain
$30 -> $41
2025-10-29
Reason
BTIG
David Larsen
Price Target
$30 -> $41
2025-10-29
maintain
Buy
Reason
BTIG analyst David Larsen raised the firm's price target on BrightSpring Health to $41 from $30 and keeps a Buy rating on the shares after its Q3 earnings beat. The higher revenue guidance continues to be driven by solid momentum in Pharmacy, with infusion and specialty growing at a very rapid pace, and the firm continues to be impressed by BrightSpring's broad strength and growth across the entire business, driven by high quality care, a growing market, and thoughtful and strategic leadership, the analyst tells investors in a research note.
See All Ratings

Valuation Metrics

The current forward P/E ratio for Brightspring Health Services Inc (BTSG.O) is 28.38, compared to its 5-year average forward P/E of 23.26. For a more detailed relative valuation and DCF analysis to assess Brightspring Health Services Inc 's fair value, click here.
  • Forward PE
  • Forward EV/EBITDA
  • Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Fair
5Y Average PE
23.26
Current PE
28.38
Overvalued PE
29.45
Undervalued PE
17.08

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
10.33
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
12.01
Undervalued EV/EBITDA
8.65

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
0.27
Current PS
0.00
Overvalued PS
0.37
Undervalued PS
0.17
AI Stock Picker
AI Stock Picker

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
Net Margin - %

Trading Trends

  • Insider
  • Hedge Fund
  • Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Financial AI Agent
Financial AI Agent

BTSG News & Events

Events Timeline

(ET)
2025-12-01
10:00:00
Wells Fargo: 1.3% Rate Cut for Home Health in 2026, Positive for PNTG and BTSG
select
2025-12-01
09:50:00
CMS Finalizes 2026 Home Health Payment Policy with $405M Increase
select
link
2025-12-01
09:50:00
Wells Fargo: 5.1% Improvement in 2026 Home Health Rate Update
select
Sign Up For More Events
Sign Up For More Events

News

[object Object]
Preview
5.0
12-04NASDAQ.COM
EHC Launches New Rehabilitation Hospital in Lake Worth to Address Growing Need

  • New Facility Opening: Encompass Health Corporation has opened the Encompass Health Rehabilitation Hospital of Lake Worth in Florida, featuring 50 beds and advanced rehabilitation technologies to assist patients recovering from complex medical issues.

  • Comprehensive Care Model: The hospital employs an interdisciplinary care model, providing tailored treatment plans that include a minimum of three hours of therapy five days a week, 24/7 nursing care, and physician oversight to enhance patient mobility and quality of life.

  • Expansion Plans: EHC is expanding its presence in Florida, marking its 26th location in the state, and plans to open seven new hospitals and add beds to existing facilities in 2025, reflecting the growing demand for rehabilitation services.

  • Financial Performance: EHC's net operating revenues increased by 10.6% year-over-year in the first nine months of 2025, with its stock gaining 23.3% year-to-date, outperforming the industry average growth of 10.3%.

[object Object]
Preview
6.0
10-29Benzinga
UBS Reiterates Buy Rating for BrightSpring Health and Increases Price Target to $42

  • Real-time Intelligence: Benzinga Pro offers traders the fastest news alerts to stay updated on market movements.

  • Exclusive Content: Subscribers gain access to unique stories and insights generated by Benzinga reporters.

  • Community of Traders: Over 10,000 serious traders are part of the Benzinga Pro community, enhancing their trading strategies.

  • Market Winning Tools: The platform is designed to help traders succeed in the markets with accurate stock market intelligence.

[object Object]
Preview
8.5
10-21Newsfilter
BrightSpring Reveals Pricing for Secondary Common Stock Offering and Simultaneous Share Buyback

  • Secondary Offering Announcement: BrightSpring Health Services has priced a secondary offering of 15,000,000 shares of common stock by certain stockholders, including an affiliate of Kohlberg Kravis Roberts & Co. L.P., with proceeds going entirely to the Selling Stockholders.

  • Share Repurchase Plan: Concurrently, BrightSpring has authorized the purchase of 1,500,000 shares from the underwriter at the same price as the offering, with the closing of this repurchase expected to occur simultaneously with the offering's closing on October 22, 2025.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is Brightspring Health Services Inc (BTSG) stock price today?

The current price of BTSG is 35.16 USD — it has increased 0.11 % in the last trading day.

arrow icon

What is Brightspring Health Services Inc (BTSG)'s business?

BrightSpring Health Services, Inc. provides home and community-based pharmacy and health solutions for populations in need of specialized and/or chronic care. Through the Company’s service lines, including pharmacy, home health care and primary care, and rehabilitation and behavioral health, it provides integrated care and clinical solutions in all 50 states to over 450,000 customers, clients and patients daily. With a focus on senior and specialty patients, the Company’s platform provides pharmacy and provider services (both clinical and supportive care in nature) in lower-cost home and community settings largely to medicare, medicaid, and commercially insured populations. It delivers services through two reportable segments: Pharmacy Solutions and Provider Services. It provides pharmacy services when and where demanded and as required by customers and patients in their homes and communities, often in coordination with its provider’s services.

arrow icon

What is the price predicton of BTSG Stock?

Wall Street analysts forecast BTSG stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for BTSG is 38.89 USD with a low forecast of 30.00 USD and a high forecast of 42.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is Brightspring Health Services Inc (BTSG)'s revenue for the last quarter?

Brightspring Health Services Inc revenue for the last quarter amounts to 3.33B USD, increased 28.17 % YoY.

arrow icon

What is Brightspring Health Services Inc (BTSG)'s earnings per share (EPS) for the last quarter?

Brightspring Health Services Inc. EPS for the last quarter amounts to 0.26 USD, decreased -750.00 % YoY.

arrow icon

What changes have occurred in the market's expectations for Brightspring Health Services Inc (BTSG)'s fundamentals?

The market is revising Upward the revenue expectations for BrightSpring Health Services, Inc. (BTSG) for FY2025, with the revenue forecasts being adjusted by 1.81% over the past three months. During the same period, the stock price has changed by 45.71%.
arrow icon

How many employees does Brightspring Health Services Inc (BTSG). have?

Brightspring Health Services Inc (BTSG) has 37000 emplpoyees as of December 05 2025.

arrow icon

What is Brightspring Health Services Inc (BTSG) market cap?

Today BTSG has the market capitalization of 6.34B USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free